ProCE Banner Activity

Key Slides on Individualized Choices in Antiretroviral Therapy

Slideset Download
Case Challenge
Expert-authored slides covering the latest data and guidelines on patient-centered ART selection for treatment-naive and virologically suppressed patients. Topics include assessing treatment options, individualizing ART for women of childbearing potential and during pregnancy, patients with OIs, and during the COVID-19 pandemic, as well as new data on investigational ART strategies.

Released: November 05, 2021

Expiration: November 04, 2022

Share

Faculty

Jean-Michel Molina

Jean-Michel Molina, MD, PhD

Professor of Infectious Diseases
University of Paris Cité
Head of the Department of Infectious Diseases
Hospital Saint-Louis and lariboisière
Paris, France

Cristina Mussini

Cristina Mussini, MD

Director of Infectious Diseases Clinics
Professor of Infectious Diseases
University of Modena School of Medicine
Modena, Italy

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Gilead Sciences, Inc.

Faculty Disclosure

Primary Author

Jean-Michel Molina, MD, PhD

Professor of Infectious Diseases
University of Paris Cité
Head of the Department of Infectious Diseases
Hospital Saint-Louis and lariboisière
Paris, France

Jean-Michel Molina, MD, PhD, has disclosed that he has received funds for research support from Gilead Sciences and consulting fees from Bristol-Myers Squibb, Gilead Sciences, Merck, and ViiV Healthcare

Cristina Mussini, MD

Director of Infectious Diseases Clinics
Professor of Infectious Diseases
University of Modena School of Medicine
Modena, Italy

Cristina Mussini, MD, has disclosed that she has received consulting fees from AbbVie, Angelini, Gilead Sciences, Janssen, MSD, and ViiV Healthcare and funds for research support from Gilead Sciences, Janssen, MSD, and ViiV Healthcare

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD, has disclosed that she has received consulting fees, fees for non-CME/CE services, and funds for research support from Gilead Sciences, GlaxoSmithKline, Janssen, MSD, and ViiV Healthcare